Investing.com - HUTCHMED DRC reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
HUTCHMED DRC announced earnings per share of $-0.25 on revenue of $356.1M. Analysts polled by Investing.com anticipated EPS of $-0.42 on revenue of $170.35M.
HUTCHMED DRC shares are down 25.34% from the beginning of the year and are trading at $26.19 , down-from-52-week-high.They are under-performing the Nasdaq which is down 12.1% from the start of the year.
HUTCHMED DRC follows other major Healthcare sector earnings this month
HUTCHMED DRC's report follows an earnings matched by Roche Holding ADR on February 3, who reported EPS of $1.29 on revenue of $17.54B, compared to forecasts EPS of $1.29 on revenue of $17.1B.
Pfizer had beat expectations on February 8 with fourth quarter EPS of $1.08 on revenue of $23.84B, compared to forecast for EPS of $0.8742 on revenue of $24.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar